ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Global Cancer Immunotherapy Market Report 2017-2022 – PR Newswire (press release)

Continue reading

2017-10-26 Michael Zand NEWS

Duration of Immunotherapy for NSCLC – OncLive


Newshawk Time

Global Cancer Immunotherapy Market Report 2017-2022
PR Newswire (press release)
reveals that the cancer immunotherapy space will be a significant revenue generator (excess of $80 billion) for the biopharmaceutical industry by 2020. The market has been supported by the approval of Bristol-Myers’ Yervoy drug for melanoma, BMS’s …
Global Cancer Immunotherapy Market Analysis & Forecast to 2022 – Research and MarketsBusiness Wire (press release)
Cancer Immunotherapy Market Analysis, Industry Chain Related Technical Experts Analysis and Forecasts Till 2021Digital Journal
Immunotherapy Drugs Market : Size, Share, Analysis and Forecast 2025Medgadget (blog)

all 49 news articles »

Continue reading

2017-10-26 Michael Zand NEWS

Voyager’s AADC Gene Therapy Shows Promise as Maintenance Therapy for Parkinson’s – Parkinson’s News Today

Duration of Immunotherapy for NSCLC
OncLive
So, it seems to me that probably the most important study to be done is not this type of study, but it’s a study that is looking about the opportunity to continue immunotherapy for those patients who are in CR or PR. And probably we need to do a …

and more »

Continue reading

2017-10-26 Michael Zand NEWS

New Version of CRISPR, Developed by Feng Zhang–Led Team, Can Target and Edit RNA – Genetic Engineering & Biotechnology News


Parkinson’s News Today

Voyager’s AADC Gene Therapy Shows Promise as Maintenance Therapy for Parkinson’s
Parkinson’s News Today
The company presented ongoing Phase 1b trial (NCT01973543) results at the Oct. 17-20 Congress of the European Society of Gene and Cell Therapy (ESGCT) in Berlin, in a talk titled “Intraputaminal AADC gene therapy for advanced Parkinson’s disease: …

Continue reading

2017-10-26 Michael Zand NEWS

Bitter CRISPR patent war intensifies – Nature.com

Nature.comBitter CRISPR patent war intensifiesNature.comAt stake are intellectual-property rights to the use of CRISPR–Cas9 gene-editing tools in eukaryotes, organisms such as plants and animals. This would include applications of the technique to trea… Continue reading

2017-10-26 Michael Zand NEWS

Bitter CRISPR patent war intensifies – Nature.com

Nature.comBitter CRISPR patent war intensifiesNature.comAt stake are intellectual-property rights to the use of CRISPR–Cas9 gene-editing tools in eukaryotes, organisms such as plants and animals. This would include applications of the technique to trea… Continue reading

2017-10-26 Michael Zand NEWS

Gene editing takes another step forward – The Economist

The EconomistGene editing takes another step forwardThe EconomistAnd another enzyme, Cpf1, is growing rapidly in popularity as a substitute for Cas9 in conjunction with CRISPR. The researchers who have developed base editing even dream of reaching into… Continue reading

2017-10-26 Michael Zand NEWS

Unapproved stem cell therapy leaves elderly women blind – Genetic Literacy Project

Genetic Literacy ProjectUnapproved stem cell therapy leaves elderly women blindGenetic Literacy Project[E]ye doctors based primarily at the Bascom Palmer Eye Institute in Miami had published a widely covered report describing three eerily similar cases… Continue reading

2017-10-26 Michael Zand NEWS
  • 1
  • …
  • 985
  • 986
  • 987
  • 988
  • 989
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Genetic Engineering & Biotechnology News

New Version of CRISPR, Developed by Feng Zhang–Led Team, Can Target and Edit RNA
Genetic Engineering & Biotechnology News
A research team led by Feng Zhang, Ph.D., has developed a new version of the gene-editing tool CRISPR (clustered regularly interspaced short palindromic repeats) that offers several advantages over its familiar DNA-editing counterpart through its …
Gene-editing tool CRISPR can now manipulate more types of genetic materialThe Verge
CRISPR 2.0 Is Here, and It’s Way More PreciseMIT Technology Review
New CRISPR tool alters RNA for wider gene editing applicationsEngadget
Science Magazine –WIRED –STAT –Science
all 69 news articles »